Hopp til innhold

Neonatal medisin

Behandling av hyperbilirubinemi

Fototerapi

Randomised controlled trial of single phototherapy with reflecting curtains versus double phototherapy in term newborns with hyperbilirubinaemia. (åpner nytt vindu)

Abd Hamid IJ, M Iyen MI, Ibrahim NR, Abd Majid N, Ramli N, Van Rostenberghe H.

Kilde‎: J Paediatr Child Health 2013;49(5):375-9.

Arkiv‎: PubMed 23573836

DOI‎: 10.1111/jpc.12192

https://www.ncbi.nlm.nih.gov/pubmed/23573836 (åpner nytt vindu)

Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. (åpner nytt vindu)

Bhutani VK; Committee on Fetus and Newborn; American Academy of Pediatrics.

Kilde‎: Pediatrics 2011;128(4):e1046-52.

Arkiv‎: PubMed 21949150

DOI‎: 10.1542/peds.2011-1494

https://www.ncbi.nlm.nih.gov/pubmed/21949150 (åpner nytt vindu)

High-intensity phototherapy for the treatment of severe nonhaemolytic neonatal hyperbilirubinemia. (åpner nytt vindu)

de Carvalho M, Mochdece CC, Sá CA, Moreira ME.

Kilde‎: Acta Paediatr 2011;100(4):620-3.

Arkiv‎: PubMed 21251060

DOI‎: 10.1111/j.1651-2227.2011.02170.x

https://www.ncbi.nlm.nih.gov/pubmed/21251060 (åpner nytt vindu)

Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost white reflecting curtains. (åpner nytt vindu)

Djokomuljanto S, Quah BS, Surini Y, Noraida R, Ismail NZ, Hansen TW, Van Rostenberghe H.

Kilde‎: Arch Dis Child Fetal Neonatal Ed 2006;91(6):F439-42.

Arkiv‎: PubMed 16877479

DOI‎: 10.1136/adc.2006.095687

https://www.ncbi.nlm.nih.gov/pubmed/16877479 (åpner nytt vindu)

Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia. (åpner nytt vindu)

Gholitabar M, McGuire H, Rennie J, Manning D, Lai R.

Kilde‎: Cochrane Database Syst Rev 2012;(12):CD009017.

Arkiv‎: PubMed 23235669

DOI‎: 10.1002/14651858.CD009017.pub2

https://www.ncbi.nlm.nih.gov/pubmed/23235669 (åpner nytt vindu)

Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. (åpner nytt vindu)

Kumar P, Chawla D, Deorari A.

Kilde‎: Cochrane Database Syst Rev 2011;(12):CD007969.

Arkiv‎: PubMed 22161417

DOI‎: 10.1002/14651858.CD007969.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22161417 (åpner nytt vindu)

Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study. (åpner nytt vindu)

Morris BH, Tyson JE, Stevenson DK, Oh W, Phelps DL, O'Shea TM, McDavid GE, Van Meurs KP, Vohr BR, Grisby C, Yao Q, Kandefer S, Wallace D, Higgins RD.

Kilde‎: J Perinatol 2013;33(2):126-33.

Arkiv‎: PubMed 22499082

DOI‎: 10.1038/jp.2012.39

https://www.ncbi.nlm.nih.gov/pubmed/22499082 (åpner nytt vindu)

Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. (åpner nytt vindu)

Okwundu CI, Okoromah CA, Shah PS.

Kilde‎: Cochrane Database Syst Rev 2012;(1):CD007966.

Arkiv‎: PubMed 22258977

DOI‎: 10.1002/14651858.CD007966.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22258977 (åpner nytt vindu)

The effect of clofibrate with phototherapy in late pre-term newborns with non-hemolytic jaundice. (åpner nytt vindu)

Sakha SH, Gharehbaghi MM, Rahbani ME.

Kilde‎: Indian J Med Sci 2009;63(5):174-9.

Arkiv‎: PubMed 19584487

DOI‎: 10.4103/0019-5359.53162

https://www.ncbi.nlm.nih.gov/pubmed/19584487 (åpner nytt vindu)

A randomized trial of phototherapy with filtered sunlight in African neonates. (åpner nytt vindu)

Slusher TM, Olusanya BO, Vreman HJ, Brearley AM, Vaucher YE, Lund TC, Wong RJ, Emokpae AA, Stevenson DK.

Kilde‎: N Engl J Med 2015;373(12):1115-24.

Arkiv‎: PubMed 26376136

DOI‎: 10.1056/NEJMoa1501074

https://www.ncbi.nlm.nih.gov/pubmed/26376136 (åpner nytt vindu)

Dose-response relationship of phototherapy for hyperbilirubinemia. (åpner nytt vindu)

Vandborg PK, Hansen BM, Greisen G, Ebbesen F.

Kilde‎: Pediatrics 2012;130(2):e352-7.

Arkiv‎: PubMed 22802603

DOI‎: 10.1542/peds.2011-3235

https://www.ncbi.nlm.nih.gov/pubmed/22802603 (åpner nytt vindu)

Intravenøs immunglobulin

High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. (åpner nytt vindu)

Alpay F, Sarici SU, Okutan V, Erdem G, Ozcan O, Gökçay E.

Kilde‎: Acta Paediatr 1999;88(2):216-9.

Arkiv‎: PubMed 10102158

https://www.ncbi.nlm.nih.gov/pubmed/10102158 (åpner nytt vindu)

High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. (åpner nytt vindu)

Dağoğlu T, Ovali F, Samanci N, Bengisu E.

Kilde‎: J Int Med Res 1995;23(4):264-71.

Arkiv‎: PubMed 7589769

DOI‎: 10.1177/030006059502300406

https://www.ncbi.nlm.nih.gov/pubmed/7589769 (åpner nytt vindu)

Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and ABO incompatibility. (åpner nytt vindu)

Huizing K, Røislien J, Hansen T.

Kilde‎: Acta Paediatr 2008;97(10):1362-5.

Arkiv‎: PubMed 18616629

DOI‎: 10.1111/j.1651-2227.2008.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/18616629 (åpner nytt vindu)

Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. (åpner nytt vindu)

Miqdad AM, Abdelbasit OB, Shaheed MM, Seidahmed MZ, Abomelha AM, Arcala OP.

Kilde‎: J Matern Fetal Neonatal Med 2004;16(3):163-6.

Arkiv‎: PubMed 15590442

DOI‎: 10.1080/14767050400009873

https://www.ncbi.nlm.nih.gov/pubmed/15590442 (åpner nytt vindu)

Tinn mesoporfyrin

Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia. (åpner nytt vindu)

Bhutani VK, Poland R, Meloy LD, Hegyi T, Fanaroff AA, Maisels MJ.

Kilde‎: J Perinatol 2016;36(7):533-9.

Arkiv‎: PubMed 26938918

DOI‎: 10.1038/jp.2016.22

https://www.ncbi.nlm.nih.gov/pubmed/26938918 (åpner nytt vindu)

Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant. (åpner nytt vindu)

Reddy P, Najundaswamy S, Mehta R, Petrova A, Hegyi T.

Kilde‎: J Perinatol 2003;23(6):507-8.

Arkiv‎: PubMed 13679941

DOI‎: 10.1038/sj.jp.7210943

https://www.ncbi.nlm.nih.gov/pubmed/13679941 (åpner nytt vindu)

Andre legemidler

Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. (åpner nytt vindu)

Honar N, Ghashghaei Saadi E, Saki F, Pishva N, Shakibazad N, Hosseini Teshnizi S.

Kilde‎: J Pediatr Gastroenterol Nutr 2016;62(1):97-100.

Arkiv‎: PubMed 26020375

DOI‎: 10.1097/MPG.0000000000000874

https://www.ncbi.nlm.nih.gov/pubmed/26020375 (åpner nytt vindu)

Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications. (åpner nytt vindu)

Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF.

Kilde‎: Pediatrics 2009;124(4):1193-8.

Arkiv‎: PubMed 19786452

DOI‎: 10.1542/peds.2009-0329

https://www.ncbi.nlm.nih.gov/pubmed/19786452 (åpner nytt vindu)

A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. (åpner nytt vindu)

Mehta S, Kumar P, Narang A.

Kilde‎: J Pediatr 2005;147(6):781-5.

Arkiv‎: PubMed 16356431

DOI‎: 10.1016/j.jpeds.2005.07.026

https://www.ncbi.nlm.nih.gov/pubmed/16356431 (åpner nytt vindu)

Treatment of clofibrate in jaundiced low birth weight neonates. [English, Turkish abstract] (åpner nytt vindu)

Mohammadzadeh A, Farhat AS, Amiri R, Esmaely H, Bagheri S.

Kilde‎: UHOD-Uluslar Hematol Onkol De (Int J Hematol Oncol) 2009;19(2):100-5.

Arkiv‎: EMBASE 2009472903

http://www.uhod.org/summary_en.php3?id=359 (åpner nytt vindu)

Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial). (åpner nytt vindu)

Zahedpasha Y, Ahmadpour-Kacho M, Hajiahmadi M, Naderi S, Kamali AA.

Kilde‎: Southeast Asian J Trop Med Public Health 2008;39(3):557-61.

Arkiv‎: PubMed 18564698

https://www.ncbi.nlm.nih.gov/pubmed/18564698 (åpner nytt vindu)